These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
10248 related items for PubMed ID: 1823927
21. Buthionine sulfoximine-induced cytostasis does not correlate with glutathione depletion. Kang YJ, Enger MD. Am J Physiol; 1992 Jan; 262(1 Pt 1):C122-7. PubMed ID: 1733228 [Abstract] [Full Text] [Related]
22. Effect of D,L-buthionine-S,R-sulfoximine on cytotoxicity and DNA cross-linking induced by bifunctional DNA-reactive cytostatic drugs in human melanoma cells. Hansson J, Edgren M, Ehrsson H, Ringborg U, Nilsson B. Cancer Res; 1988 Jan 01; 48(1):19-26. PubMed ID: 3334994 [Abstract] [Full Text] [Related]
23. Buthionine sulfoximine induction of gamma-L-glutamyl-L-cysteine synthetase gene expression, kinetics of glutathione depletion and resynthesis, and modulation of carmustine-induced DNA-DNA cross-linking and cytotoxicity in human glioma cells. Ali-Osman F, Antoun G, Wang H, Rajagopal S, Gagucas E. Mol Pharmacol; 1996 Jun 01; 49(6):1012-20. PubMed ID: 8649339 [Abstract] [Full Text] [Related]
24. Melanoma cytotoxicity of buthionine sulfoximine (BSO) alone and in combination with 3,4-dihydroxybenzylamine and melphalan. Prezioso JA, FitzGerald GB, Wick MM. J Invest Dermatol; 1992 Sep 01; 99(3):289-93. PubMed ID: 1512464 [Abstract] [Full Text] [Related]
25. Enhanced melphalan cytotoxicity in human ovarian cancer in vitro and in tumor-bearing nude mice by buthionine sulfoximine depletion of glutathione. Ozols RF, Louie KG, Plowman J, Behrens BC, Fine RL, Dykes D, Hamilton TC. Biochem Pharmacol; 1987 Jan 01; 36(1):147-53. PubMed ID: 3801051 [Abstract] [Full Text] [Related]
26. Effects of glutathione depletion by buthionine sulfoximine on radiosensitization by oxygen and misonidazole in vitro. Shrieve DC, Denekamp J, Minchinton AI. Radiat Res; 1985 Jun 01; 102(3):283-94. PubMed ID: 4070545 [Abstract] [Full Text] [Related]
27. Disulfiram induces apoptosis in human melanoma cells: a redox-related process. Cen D, Gonzalez RI, Buckmeier JA, Kahlon RS, Tohidian NB, Meyskens FL. Mol Cancer Ther; 2002 Jan 01; 1(3):197-204. PubMed ID: 12467214 [Abstract] [Full Text] [Related]
28. Identification of glutathione S-transferase as a determinant of 4-hydroperoxycyclophosphamide resistance in human breast cancer cells. Chen G, Waxman DJ. Biochem Pharmacol; 1995 May 26; 49(11):1691-701. PubMed ID: 7786310 [Abstract] [Full Text] [Related]
29. Effect of glutathione levels on aflatoxin B1-DNA binding in livers and kidneys of male rats and hamsters pretreated with buthionine sulfoximine and dimethylmaleate. Gopalan-Kriczky P, Hiruma S, Lotlikar PD. Cancer Lett; 1994 Jan 15; 76(1):25-30. PubMed ID: 8124663 [Abstract] [Full Text] [Related]
30. Toxic effects of acute glutathione depletion by buthionine sulfoximine and dimethylfumarate on murine mammary carcinoma cells. Dethlefsen LA, Lehman CM, Biaglow JE, Peck VM. Radiat Res; 1988 May 15; 114(2):215-24. PubMed ID: 3375425 [Abstract] [Full Text] [Related]
31. Depletion of tumour glutathione in vivo by buthionine sulphoximine: modulation by the rate of cellular proliferation and inhibition of cancer growth. Terradez P, Asensi M, Lasso de la Vega MC, Puertes IR, Viña J, Estrela JM. Biochem J; 1993 Jun 01; 292 ( Pt 2)(Pt 2):477-83. PubMed ID: 8503882 [Abstract] [Full Text] [Related]
32. Buthionine sulfoximine induced growth inhibition in human lung carcinoma cells does not correlate with glutathione depletion. Kang YJ, Emery D, Enger MD. Cell Biol Toxicol; 1991 Jul 01; 7(3):249-61. PubMed ID: 1933516 [Abstract] [Full Text] [Related]
33. In vivo therapeutic potential of combination thiol depletion and alkylating chemotherapy. Siemann DW, Beyers KL. Br J Cancer; 1993 Dec 01; 68(6):1071-9. PubMed ID: 8260357 [Abstract] [Full Text] [Related]
34. Suppression of plasma estradiol and progesterone concentrations by buthionine sulfoximine in female rats. Kang YJ, Uthus EO. Biochem Pharmacol; 1996 Feb 23; 51(4):567-70. PubMed ID: 8619904 [Abstract] [Full Text] [Related]
35. Depletion of glutathione by L-buthionine sulfoximine does not promote inactivation of myo-inositol transport in cultured bovine lens epithelial cells. Cammarata PR, Tse D, Yorio T. Curr Eye Res; 1991 Apr 23; 10(4):321-30. PubMed ID: 1676962 [Abstract] [Full Text] [Related]
36. Modulation of glutathione level in cultured human melanoma cells. Karg E, Brötell H, Rosengren E, Rorsman H. Acta Derm Venereol; 1989 Apr 23; 69(2):137-41. PubMed ID: 2564231 [Abstract] [Full Text] [Related]
37. Inhibition of the protective effect of cyclophosphamide by pre-treatment with buthionine sulfoximine. Carmichael J, Friedman N, Tochner Z, Adams DJ, Wolf CR, Mitchell JB, Russo A. Int J Radiat Oncol Biol Phys; 1986 Jul 23; 12(7):1191-3. PubMed ID: 3744939 [Abstract] [Full Text] [Related]
38. Contribution of glutathione and glutathione-dependent enzymes in the reversal of adriamycin resistance in colon carcinoma cell lines. Lai GM, Moscow JA, Alvarez MG, Fojo AT, Bates SE. Int J Cancer; 1991 Nov 11; 49(5):688-95. PubMed ID: 1682279 [Abstract] [Full Text] [Related]
39. Cytotoxic effects of glutathione synthesis inhibition by L-buthionine-(SR)-sulfoximine on human and murine tumor cells. Dorr RT, Liddil JD, Soble MJ. Invest New Drugs; 1986 Nov 11; 4(4):305-13. PubMed ID: 3583642 [Abstract] [Full Text] [Related]
40. Glutathione and related enzymes in rat brain tumor cell resistance to 1,3-bis(2-chloroethyl)-1-nitrosourea and nitrogen mustard. Evans CG, Bodell WJ, Tokuda K, Doane-Setzer P, Smith MT. Cancer Res; 1987 May 15; 47(10):2525-30. PubMed ID: 2882834 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]